|
1
|
Sakamoto S and Ichikawa T: Mechanism of
prostate cancer invasion and metastasis. Nihon Rinsho.
72:2086–2089. 2014.(In Japanese). PubMed/NCBI
|
|
2
|
Ombrato L and Malanchi I: The EMT
universe: Space between cancer cell dissemination and metastasis
initiation. Crit Rev Oncog. 19:349–361. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu H, Ren G, Wang T, Chen Y, Gong C, Bai
Y, Wang B, Qi H, Shen J, Zhu L, et al: Aberrantly expressed Fra-1
by IL-6/STAT3 transactivation promotes colorectal cancer
aggressiveness through epithelial-mesenchymal transition.
Carcinogenesis. 36:459–468. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Safe S and Abdelrahim M: Sp transcription
factor family and its role in cancer. Eur J Cancer. 41:2438–2448.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Beishline K and Azizkhan-Clifford J: Sp1
and the ‘hallmarks of cancer’. FEBS J. 282:224–258. 2015.
View Article : Google Scholar
|
|
6
|
Li S, Wang Q, Qiang Q, Shan H, Shi M, Chen
B, Zhao S and Yuan L: Sp1-mediated transcriptional regulation of
MALAT1 plays a critical role in tumor. J Cancer Res Clin Oncol.
141:1909–1920. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sankpal UT, Goodison S, Abdelrahim M and
Basha R: Targeting Sp1 transcription factors in prostate cancer
therapy. Med Chem. 7:518–525. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nam EH, Lee Y, Park YK, Lee JW and Kim S:
ZEB2 upregulates integrin α5 expression through cooperation with
Sp1 to induce invasion during epithelial-mesenchymal transition of
human cancer cells. Carcinogenesis. 33:563–571. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Karkhanis M and Park JI: Sp1 regulates
Raf/MEK/ERK-induced p21(CIP1) transcription in TP53-mutated cancer
cells. Cell Signal. 27:479–486. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Katoh M: Epithelial-mesenchymal transition
in gastric cancer (Review). Int J Oncol. 27:1677–1683.
2005.PubMed/NCBI
|
|
11
|
Jiang W, Jin Z, Zhou F, Cui J and Wang L
and Wang L: High co-expression of Sp1 and HER-2 is correlated with
poor prognosis of gastric cancer patients. Surg Oncol. 24:220–225.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou C, Ji J, Cai Q, Shi M, Chen X, Yu Y,
Liu B, Zhu Z and Zhang J: MTA2 promotes gastric cancer cells
invasion and is transcriptionally regulated by Sp1. Mol Cancer.
12:1022013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo MM, Hu LH, Wang YQ, Chen P, Huang JG,
Lu N, He JH and Liao CG: miR-22 is down-regulated in gastric
cancer, and its overexpression inhibits cell migration and invasion
via targeting transcription factor Sp1. Med Oncol. 30:5422013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jungert K, Buck A, von Wichert G, Adler G,
König A, Buchholz M, Gress TM and Ellenrieder V: Sp1 is required
for transforming growth factor-beta-induced mesenchymal transition
and migration in pancreatic cancer cells. Cancer Res. 67:1563–1570.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jia L, Ma X, Gui B, Ge H, Wang L, Ou Y,
Tian L, Chen Z, Duan Z, Han J, et al: Sorafenib ameliorates renal
fibrosis through inhibition of TGF-β-induced epithelial-mesenchymal
transition. PLoS One. 10:e01177572015. View Article : Google Scholar
|
|
16
|
Chen XH, Liu ZC, Zhang G, Wei W, Wang XX,
Wang H, Ke HP, Zhang F, Wang HS, Cai SH, et al: TGF-β and EGF
induced HLA-I downregulation is associated with
epithelial-mesenchymal transition (EMT) through upregulation of
snail in prostate cancer cells. Mol Immunol. 65:34–42. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li PF, Chen SC, Xia T, Jiang XM, Shao YF,
Xiao BX and Guo JM: Non-coding RNAs and gastric cancer. World J
Gastroenterol. 20:5411–5419. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang M, Shan X, Zhou X, Qiu T, Zhu W, Ding
Y, Shu Y and Liu P: miR-1271 regulates cisplatin resistance of
human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and
BCL2. Anticancer Agents Med Chem. 14:884–891. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jin Z, Jiang W and Wang L: Biomarkers for
gastric cancer: Progression in early diagnosis and prognosis
(Review). Oncol Lett. 9:1502–1508. 2015.PubMed/NCBI
|
|
21
|
Hu J, Fang Y, Cao Y, Qin R and Chen Q:
miR-449a regulates proliferation and chemosensitivity to cisplatin
by targeting cyclin D1 and BCL2 in SGC7901 cells. Dig Dis Sci.
59:336–345. 2014. View Article : Google Scholar
|
|
22
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Toden S, Okugawa Y, Jascur T, Wodarz D,
Komarova NL, Buhrmann C, Shakibaei M, Boland CR and Goel A:
Curcumin mediates chemosensitization to 5-fluorouracil through
miRNA-induced suppression of epithelial-to-mesenchymal transition
in chemoresistant colorectal cancer. Carcinogenesis. 36:355–367.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Z, Sun J, Bai Z, Li H, He S, Chen R
and Che X: MicroRNA-153 acts as a prognostic marker in gastric
cancer and its role in cell migration and invasion. Onco Targets
Ther. 8:357–364. 2015.PubMed/NCBI
|
|
25
|
Kulesa PM and McLennan R: Neural crest
migration: Trailblazing ahead. F1000Prime Rep. 7:022015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maritzen T, Schachtner H and Legler DF: On
the move: Endocytic trafficking in cell migration. Cell Mol Life
Sci. 72:2119–2134. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deng B, Zhang S, Miao Y, Zhang Y, Wen F
and Guo K: Down-regulation of Frizzled-7 expression inhibits
migration, invasion, and epithelial-mesenchymal transition of
cervical cancer cell lines. Med Oncol. 32:1022015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Greening DW, Gopal SK, Mathias RA, Liu L,
Sheng J, Zhu HJ and Simpson RJ: Emerging roles of exosomes during
epithelial-mesenchymal transition and cancer progression. Semin
Cell Dev Biol. 40:60–71. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yuan W, Yuan Y, Zhang T and Wu S: Role of
Bmi-1 in regulation of ionizing irradiation-induced
epithelial-mesenchymal transition and migration of breast cancer
cells. PLoS One. 10:e01187992015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Choi YJ, Kim N, Chang H, Lee HS, Park SM,
Park JH, Shin CM, Kim JM, Kim JS, Lee DH, et al: Helicobacter
pylori-induced epithelial-mesenchymal transition, a potential role
of gastric cancer initiation and an emergence of stem cells.
Carcinogenesis. 36:553–563. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin J, Liu X and Ding D: Evidence for
epithelial-mesenchymal transition in cancer stem-like cells derived
from carcinoma cell lines of the cervix uteri. Int J Clin Exp
Pathol. 8:847–855. 2015.PubMed/NCBI
|
|
32
|
Zhang Y, Du J, Zheng J, Liu J, Xu R, Shen
T, Zhu Y, Chang J, Wang H, Zhang Z, et al: EGF-reduced Wnt5a
transcription induces epithelial-mesenchymal transition via
Arf6-ERK signaling in gastric cancer cells. Oncotarget.
6:7244–7261. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lu W, Xu Z, Zhang M and Zuo Y: MiR-19a
promotes epithelial-mesenchymal transition through PI3K/AKT pathway
in gastric cancer. Int J Clin Exp Pathol. 7:7286–7296.
2014.PubMed/NCBI
|
|
34
|
Black AR, Black JD and Azizkhan-Clifford
J: Sp1 and krüppel-like factor family of transcription factors in
cell growth regulation and cancer. J Cell Physiol. 188:143–160.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Choi ES, Nam JS, Jung JY, Cho NP and Cho
SD: Modulation of specificity protein 1 by mithramycin A as a novel
therapeutic strategy for cervical cancer. Sci Rep. 4:71622014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu TP, Liu XX, Xia R, Yin L, Kong R, Chen
WM, Huang MD and Shu YQ: SP1-induced upregulation of the long
noncoding RNA TINCR regulates cell proliferation and apoptosis by
affecting KLF2 mRNA stability in gastric cancer. Oncogene.
34:5648–5661. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yao Y, Hu J, Shen Z, Yao R, Liu S, Li Y,
Cong H, Wang X, Qiu W and Yue L: MiR-200b expression in breast
cancer: A prognostic marker and act on cell proliferation and
apoptosis by targeting Sp1. J Cell Mol Med. 19:760–769. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhao S, Wu J, Zheng F, Tang Q, Yang L, Li
L, Wu W and Hann SS: β-elemene inhibited expression of DNA
methyltransferase 1 through activation of ERK1/2 and AMPKα
signalling pathways in human lung cancer cells: The role of Sp1. J
Cell Mol Med. 19:630–641. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Qiu T, Zhou X, Wang J, Du Y, Xu J, Huang
Z, Zhu W, Shu Y and Liu P: MiR-145, miR-133a and miR-133b inhibit
proliferation, migration, invasion and cell cycle progression via
targeting transcription factor Sp1 in gastric cancer. FEBS Lett.
588:1168–1177. 2014. View Article : Google Scholar : PubMed/NCBI
|
